CLOs on the Move

Oxford Medical Simulation

www.oxfordmedicalsimulation.com

 
Oxford Medical Simulation delivers virtual reality medical simulation - training healthcare professionals to provide consistently world-class patient management without risking lives. Medical simulation has become central to medical training and is highly effective. However, it is expensive, low throughput and not widely accessible. Healthcare workers therefore struggle to get the training they need to deliver optimal patient care. We remove these barriers by offering virtual reality training scenarios. These provide a completely safe, controlled-stress learning environment for all healthcare professionals. The focus is on clinical decision-making under pressure, crisis resource management, team interaction and patient engagement. Our fast-paced, repeatable, real-life ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Anna Jaques Hospital

Anna Jaques Hospital is dedicated to providing quality medical care to aging adults. We provide patient and family-centered care that focuses on the health and illnesses of the aging adult.

Critical Concepts

Critical Concepts is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Annapolis Yacht Club

Welcome to Annapolis Yacht Club Junior sailing page. Keep up with the activities of the Junior Sailing program throughout the year.

Hospice of Central Michigan

Hospice of Central Michigan is a Mount Pleasant, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.